Evidence map›Paper›PMID 42133541›Full record

Observational studyBrain and behavior2026

Leukocyte Telomere Length and Its Polygenic Risk Score in Post-Stroke Cognitive Impairment: Evidence From a Multicenter Cohort Study.

Kunying Zhao, Yanfeng Shi, Hongyi Yan, Hongyu Zhou, Jiejie Li, Si Cheng, Zhe Xu, Yuesong Pan, Zixiao Li, Xia Meng and 4 more

Abstract readMulticenter StudyObservational Study
In one paragraph

Observational study in Brain and behavior, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Kunying ZhaoDepartment of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
Yanfeng ShiChina National Clinical Research Center For Neurological Diseases, Beijing, China.
Hongyi YanChina National Clinical Research Center For Neurological Diseases, Beijing, China.
Hongyu ZhouDepartment of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
Jiejie LiDepartment of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
Si ChengDepartment of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
Zhe XuChina National Clinical Research Center For Neurological Diseases, Beijing, China.
Yuesong PanChina National Clinical Research Center For Neurological Diseases, Beijing, China.
Zixiao LiDepartment of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
Xia MengDepartment of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
Hao LiChina National Clinical Research Center For Neurological Diseases, Beijing, China.
Xiaoling LiaoDepartment of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
Jing JingDepartment of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
Yongjun WangDepartment of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.

Funding

Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences 2019-I2M-5-029National Key Research and Development Program of China 2022YFC2502400National Key Research and Development Program of China 2022YFC2502404National Natural Science Foundation of China 82111530203
6 · The paper itself

Abstract

backgroundPost-stroke cognitive impairment (PSCI) is a frequent and disabling consequence of ischemic stroke. Leukocyte telomere length (LTL), a biomarker of systemic biological aging, has been implicated in cognitive outcomes, but evidence in stroke populations remains limited. We investigated whether baseline LTL and an LTL polygenic risk score (LTL-PRS) are associated with PSCI risk in a large Chinese stroke cohort.

methodsWe analyzed patients with ischemic stroke or transient ischemic attack (TIA) from the Third China National Stroke Registry-impairment of cognition and sleep (CNSR-III-ICONS) sub study. Baseline LTL was estimated from whole-genome sequencing (WGS) using TelSeq. An 18-SNP LTL-PRS (East-Asian weights) was z-standardized. Cognitive status at 12 months was assessed using the Montreal Cognitive Assessment (MoCA); PSCI was defined as an age-, sex-, education-adjusted norm-referenced threshold (z score ≤ -1.5). Fifty-one participants missing education required for the adjusted PSCI definition were excluded, leaving 923 for analysis. Multivariable logistic regression tested associations of LTL and LTL-PRS with PSCI, with exploratory interaction and stratified analyses by age, sex, and stroke subtype.

resultsPSCI occurred in 191 of 923 patients (20.7%). Neither continuous LTL nor LTL-PRS was associated with PSCI overall. Exploratory analyses provided nominal evidence of heterogeneity by age (p-interaction = 0.038) and stroke subtype (p-interaction = 0.01), whereas evidence for sex interaction was inconclusive (p-interaction = 0.07). Associations with the MoCA executive function domain were weak and sensitive to covariate adjustment.

conclusionsBaseline telomere metrics showed, at most, modest and context-dependent associations with PSCI. Neither LTL nor this limited-variant LTL-PRS demonstrated overall prognostic utility, highlighting the need for integrated, longitudinal multi-omic approaches for individualized cognitive risk prediction after stroke.

Indexed as

Cognitive DysfunctionIschemic StrokeLeukocytesStrokeTelomereTelomere HomeostasisAgedChinaCohort StudiesFemaleGenetic Risk ScoreHumansIschemic Attack, TransientMaleMiddle Agedagingpolygenic risk scorepost‐stroke cognitive impairmentstroketelomere length

Identifiers

PMID42133541
PMCPMC13175197

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.